Biomarker Testing in Gastrointestinal and Lung Cancers
Comprehensive insights on biomarker testing practices for patients with lung or gastrointestinal cancers.
Stay updated with breaking news from Molecular Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Comprehensive insights on biomarker testing practices for patients with lung or gastrointestinal cancers.
A breast medical oncologist and nurse practitioner review molecular testing practices for patients with breast cancer.
Patients with polycythemia vera (PV) and essential thrombocythemia (ET) require repeated molecular testing and improved prognostic tools.
AstraZeneca and Daiichi Sankyo’s ENHERTU showed objective response rates of 49% and 56% with 5.4mg/kg and 6.4mg/kg doses respectively in primary analysis ENHERTU provided a median...
Oncocyte's VitaGraft Kidney Transplant Diagnostic Test Receives CMS ...